Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies.

PloS one - 10 Nov 2010

Shaltiel-Karyo Ronit, Frenkel-Pinter Moran, Egoz-Matia Nirit, Frydman-Marom Anat, Shalev Deborah E, Segal Daniel, Gazit Ehud

Abstract excerpt

The intracellular oligomerization of α-synuclein is associated with Parkinson's disease and appears to be an important target for disease-modifying treatment. Yet, to date, there is no specific inhibitor for this aggregation process. Using unbiased systematic peptide array analysis, we identified molecular interaction domains within the β-synuclein polypeptide that specifically binds α-synuclein. Adding such...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Synuclein
Share to Amyloid

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Animals, Genetically Modified

Share to Magnetic Resonance Spectroscopy

Share to Parkinson Disease

Share to Peptide Fragments

Share to Protein Interaction Mapping

Share to Protein Multimerization

Source

Open in PubMed Open full text

Identifiers

PMID: 21085664
DOI: 10.1371/journal.pone.0013863
PMCID: PMC2978097

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies.PMID 21085664Read ↗

The aggregation of α-synuclein and its inhibtionSemantic proximity Read ↗

A targetable N-terminal motif orchestrates α-Synuclein oligomer to fibril conversionSemantic proximity Read ↗

The good and bad of therapeutic strategies that directly target α‐synucleinSemantic proximity Read ↗

Conformational Dynamics of α-Synuclein: A Study of its Intramolecular Forces in the Presence of Selected CompoundsSemantic proximity Read ↗

Modulating the Amyloidogenesis of α-Synuclein.Semantic proximity Read ↗

Direct disassembly of α-syn preformed fibrils into native α-syn monomers by an all-D-peptideSemantic proximity Read ↗

A <i>de novo</i> compound targeting α-synuclein improves deficits in models of Parkinson's diseaseSemantic proximity Read ↗

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsSemantic proximity Read ↗

Foldamers Reveal and Validate Novel Therapeutic Targets Associated with Toxic α-Synuclein Self-AssemblySemantic proximity Read ↗

Inhibition of α-Synuclein Seeding-Dependent Aggregation by ssDNA Aptamers Specific to C-Terminally Truncated α-Synuclein FibrilsSemantic proximity Read ↗

Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomersSemantic proximity Read ↗

Rationally Designed Variants of α-Synuclein Illuminate Its in vivo Structural Properties in Health and DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.